Privia Health Group, Inc. (PRVA)

Privia Health Group Stock Forecast

Stock Price Forecast

The 15 analysts that cover Privia Health Group stock have a consensus rating of "Strong Buy" and an average price target of $30.8, which forecasts a 41.48% increase in the stock price over the next year. The lowest target is $23 and the highest is $36.

Price Target: $30.8 (+41.48%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$23	$30.8	$31	$36
Change	+5.65%	+41.48%	+42.40%	+65.37%

Analyst Ratings

The average analyst rating for Privia Health Group stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	4	4	4	4	4	5
Buy	9	9	9	9	9	9
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	14	14	14	14	14	15

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Daniel Grosslight Citigroup	Citigroup	Strong Buy Maintains $34 → $32	Strong Buy	Maintains	$34 → $32	+46.99%	Mar 3, 2026
Jailendra Singh Truist Securities	Truist Securities	Strong Buy Maintains $31 → $33	Strong Buy	Maintains	$31 → $33	+51.58%	Mar 2, 2026
Richard Close Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $34 → $35	Strong Buy	Maintains	$34 → $35	+60.77%	Feb 27, 2026
Ryan Halsted RBC Capital	RBC Capital	Buy Initiates $31	Buy	Initiates	$31	+42.40%	Jan 9, 2026
Jeff Garro Stephens & Co.	Stephens & Co.	Buy Reiterates $32	Buy	Reiterates	$32	+46.99%	Dec 4, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

2.49B

Increased by 17.25%

from 2.12B

Revenue Next Year

2.68B

Increased by 7.71%

from 2.49B

EPS This Year

0.35

Increased by 94.61%

from 0.18

EPS Next Year

0.47

Increased by 32.97%

from 0.35

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	966.22M	1.36B	1.66B	1.74B	2.12B	2.49B	2.68B
Revenue Growth	18.25%	40.41%	22.19%	4.75%	22.26%	17.25%	7.71%
EPS	-1.83	-0.08	0.19	0.11	0.18	0.35	0.47
EPS Growth	-	-	-	-42.11%	63.64%	94.61%	32.97%
Forward PE	-	-	-	-	-	62.15	46.74
No. Analysts	-	-	-	-	-	23	20

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029	2030
High	4.0B	2.9B
Avg	2.5B	2.7B
Low	2.2B	2.4B

Revenue Growth

Revenue Growth	2026	2027	2028	2029	2030
High	89.7%	16.5%
Avg	17.2%	7.7%
Low	5.1%	-2.0%

EPS Forecast

EPS	2026	2027	2028
High	0.50	0.68
Avg	0.35	0.47
Low	0.24	0.30

EPS Growth

EPS Growth	2026	2027	2028
High	180.0%	94.8%
Avg	94.6%	33.0%
Low	30.7%	-13.3%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.